The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn’s Disease but Not Ulcerative Colitis Patients

Saved in:
Bibliographic Details
Published inPharmaceutics Vol. 15; p. 811
Main Authors Young Su Park, Sang Bum Kang, Ronald R. Marchelletta, Harrison M. Penrose, Roos Ruiter-Visser, Barbara Jung, Michael J. Docherty, Brigid S. Boland, William J. Sandborn, Declan F. McCole
Format Journal Article
LanguageJapanese
Published MDPI AG 02.03.2023
Subjects
Autoimmune Disease
chloride secretion
Clinical Research
Crohn's Disease
Digestive Diseases
epithelial
Inflammatory Bowel Disease
ion transport
occludin
Oral and gastrointestinal
permeability
Pharmacology and Pharmaceutical Sciences
Pharmacy and materia medica
RS1-441
tight junction
Online AccessGet full text
ISSN1999-4923
DOI10.3390/pharmaceutics15030811

Cover

More Information
ISSN:1999-4923
DOI:10.3390/pharmaceutics15030811